A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments

Kevin C. Barry(University of California, San Francisco), Joy Hsu(University of California, San Francisco), Miranda L. Broz(University of California, San Francisco), Francisco J. Cueto(University of California, San Francisco), Mikhail Binnewies(University of California, San Francisco), Alexis J. Combes(University of California, San Francisco), Amanda E. Nelson(University of California, San Francisco), Kimberly Loo(University of California, San Francisco), Raj Kumar(University of California, San Francisco), Michael D. Rosenblum(University of California, San Francisco), Michael Alvarado(University of California, San Francisco), Denise M. Wolf(University of California, San Francisco), Dusan Bogunovic(Icahn School of Medicine at Mount Sinai), Nina Bhardwaj(Icahn School of Medicine at Mount Sinai), Adil Daud(University of California, San Francisco), Patrick K. Ha(University of California, San Francisco), William R. Ryan(University of California, San Francisco), Joshua L. Pollack, Bushra Samad(University of California, San Francisco), Saurabh Asthana(University of California, San Francisco), Vincent Chan(University of California, San Francisco), Matthew F. Krummel(University of California, San Francisco)
Nature Medicine
June 22, 2018
Cited by 1,006

Abstract


Related Papers

No related papers found

Powered by citation graph analysis